Pro Medicus Stock Forecast

Stock Price Forecast

According to 15 analysts polled by S&P Global, Pro Medicus stock has a consensus rating of "Buy" and an average price target of $202.61. The average 1-year stock price forecast is 0.95% lower than the current stock price, while the lowest is $60.00 (-70.67%) and the highest is $250.00 (+22.21%).

Price Target: $202.61 (-0.95%)

Analyst Consensus: Buy

Price Target

Chart

Target	Low	Average	Median	High
Price	$60.00	$202.61	$222.00	$250.00
Change	-70.67%	-0.95%	+8.53%	+22.21%

Analyst Ratings

The average analyst rating for Pro Medicus stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart

Rating	Jun '26	Jul '26	Aug '26	Sep '26	Oct '26	Nov '26
Strong Buy	9	7	6	6	7	7
Buy	3	3	3	3	2	2
Hold	2	4	5	5	5	5
Sell	0	0	0	0	0	0
Strong Sell	1	1	1	1	1	1
Total	15	15	15	15	15	15

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
David Stanton Jefferies	Jefferies	Hold Maintains $196.95 → $199.00	Hold	Maintains	$196.95 → $199.00	-2.72%	Oct 20, 2026
Iain Wilkie Morgans	Morgans	Buy Maintains $230.00	Buy	Maintains	$230.00	+12.44%	Oct 19, 2026
Laura Sutcliffe Citi	Citi	Buy Maintains $225.00	Buy	Maintains	$225.00	+9.99%	Sep 23, 2026
Unknown Analyst J.P. Morgan No rating	J.P. Morgan	Hold Maintains $211.00	Hold	Maintains	$211.00	+3.15%	Aug 20, 2026
Chris Boulus Goldman Sachs	Goldman Sachs	Buy Maintains $220.00	Buy	Maintains	$220.00	+7.55%	Aug 20, 2026

More Analyst Ratings

Financial Forecast

Revenue This Year

338.67M

from 261.69M

29.42%

from 261.69M

Revenue Next Year

420.21M

from 338.67M

24.08%

from 338.67M

EPS This Year

1.88

from 1.38

36.18%

from 1.38

EPS Next Year

2.35

from 1.88

25.01%

from 1.88

Fiscal Year	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Jun 30, 2022	Jun 30, 2023	Jun 30, 2024	Jun 30, 2025	Jun 30, 2026	Jun 30, 2027
Revenue	93.46M	124.90M	161.50M	212.98M	261.69M	338.67M
Revenue Growth	37.31%	33.64%	29.30%	31.87%	22.87%	29.42%
Gross Profit	93.00M	124.36M	161.20M	212.67M	261.29M	337.32M
Gross Margin	99.50%	99.56%	99.81%	99.85%	99.85%	99.60%
Operating Income	61.31M	84.08M	112.25M	157.69M	196.12M	257.90M
Net Income	44.44M	60.65M	82.79M	115.22M	265.34M	185.66M
EPS	-	-	-	-	1.38	1.88
EPS Growth	-	-	-	-	21.02%	36.18%
Forward PE	82.65	100.34	151.89	203.41	120.09	108.98
Dividend / Share	0.22	0.30	0.40	0.55	0.69	0.94
Dividend Growth	46.67%	36.36%	33.33%	37.50%	25.46%	36.95%
Free Cash Flow	-	-	-	-	85.39M	179.47M
No. Analysts	-	-	-	-	-	14

EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is AUD.

Revenue Forecast

Chart

Revenue	2027	2028	2029
High	354.8M
Avg	338.7M
Low	321.5M

Revenue Growth

Chart

Revenue Growth	2027	2028	2029
High	35.6%
Avg	29.4%
Low	22.9%

EPS Forecast

Chart

EPS	2027	2028	2029
High	2.50
Avg	1.88
Low	1.72

EPS Growth

Chart

EPS Growth	2027	2028	2029
High	81.3%
Avg	36.2%
Low	24.9%